Pak4 siRNA/shRNA/RNAi
To Order Contact us: lieven@wlsolutions.be
PAK4 siRNA (Human) |
||
| MBS8229054-5x30nmol | 5x30nmol | EUR 2450 |
PAK4 siRNA (Mouse) |
||
| MBS8214565-15nmol | 15nmol | EUR 405 |
PAK4 siRNA (Mouse) |
||
| MBS8214565-30nmol | 30nmol | EUR 565 |
PAK4 siRNA (Mouse) |
||
| MBS8214565-5x30nmol | 5x30nmol | EUR 2450 |
Mouse PAK4 shRNA Plasmid |
||
| 20-abx977256 |
|
|
Human PAK4 shRNA Plasmid |
||
| 20-abx956978 |
|
|
Pak4 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each |
||
| SR502681 | 2 nmol | Ask for price |
Pak4 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each |
||
| SR417912 | 2 nmol | Ask for price |
PAK4 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
||
| SR306978 | 2 nmol | Ask for price |
Pak4 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
||
| TL704825 | 5 µg/vial | Ask for price |
PAK4 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector |
||
| TF320637 | 5 µg/vial | Ask for price |
PAK4 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector |
||
| TG320637 | 5 µg/vial | Ask for price |
PAK4 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
||
| TL320637 | 5 µg/vial | Ask for price |
Pak4 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
||
| TL513087 | 5 µg/vial | Ask for price |
Pak4 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector |
||
| TR704825 | 5 µg/vial | Ask for price |
PAK4 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector |
||
| TR320637 | 5 µg/vial | Ask for price |
Pak4 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector |
||
| TR513087 | 5 µg/vial | Ask for price |
pROKII- RNAI Plasmid |
||
| PVT3202 | 2ug | EUR 182 |
HighYield T7 RNAi Kit |
||
| RNT-134 | 50reactions x 20 µl | EUR 265 |
T7 RNAi Transcription Kit |
||
| TR102-01 | 25 rxn | EUR 111.64 |
T7 RNAi Transcription Kit |
||
| TR102-02 | 50 rxn | EUR 217.5 |
T7 RNAi Transcription Kit |
||
| TR102-01-25rxns | 25 rxns | EUR 115.61 |
T7 RNAi Transcription Kit |
||
| TR102-02-50rxns | 50 rxns | EUR 225.22 |
RNAi-Ready pSIREN-RetroQ |
||
| PVTY01204 | 2ug | EUR 280 |
Pak4 - Rat shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
||
| TL704825V | 500 ul each | Ask for price |
PAK4 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
||
| TL320637V | 500 ul each | Ask for price |
Pak4 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
||
| TL513087V | 500 ul each | Ask for price |
GeneGlide? RNAi Delivery Control |
||
| M1082-10 | each | EUR 284.4 |
GeneGlide? RNAi Delivery Control |
||
| M1082-100 | each | EUR 1002 |
GeneGlide? RNAi Delivery Control |
||
| M1082-50 | each | EUR 594 |
PAK4 |
||
| 40076 | 10 µg | EUR 495 |
|
Description: Human PAK4 (GenBank Accession No. BC002921), a.a. 300-591, MW=33.3 kDa, expressed in E. coli. |
||
PAK4 |
||
| CSB-CL017408HU1 | 10 μg plasmid + 200μl Glycerol | Ask for price |
PAK4 |
||
| CSB-CL017408HU2 | 10 μg plasmid + 200μl Glycerol | Ask for price |
PAK4 |
||
| pka-259 | 5µg | EUR 60 |
|
Description: Recombinant Human p21 Activated Kinase 4 |
||
PAK1 siRNA |
||
| 20-abx927641 |
|
|
PAK1 siRNA |
||
| 20-abx927642 |
|
|
PAK2 siRNA |
||
| 20-abx927643 |
|
|
PAK2 siRNA |
||
| 20-abx927644 |
|
|
PAK3 siRNA |
||
| 20-abx927645 |
|
|
PAK3 siRNA |
||
| 20-abx927646 |
|
|
PAK6 siRNA |
||
| 20-abx927649 |
|
|
PAK6 siRNA |
||
| 20-abx927650 |
|
|
PAK7 siRNA |
||
| 20-abx927651 |
|
|
PAK7 siRNA |
||
| 20-abx927652 |
|
|
PAK2 siRNA |
||
| 20-abx903828 |
|
|
PAK3 siRNA |
||
| 20-abx903829 |
|
|
PAK7 siRNA |
||
| 20-abx903830 |
|
|
RNAi-Ready pSIREN-RetroQ-ZsGreen |
||
| PVTY01206 | 2ug | EUR 280 |
RNAi-Ready pSIREN-RetroQ-ZsGreen1 |
||
| PVTY00817 | 2ug | EUR 280 |
PAK4, Active |
||
| 7707-5 | each | EUR 444 |
PAK4, Active |
||
| MBS517364-0005mg | 0.005mg | EUR 320 |
PAK4, Active |
||
| MBS517364-001mg | 0.01mg | EUR 390 |
PAK4, Active |
||
| MBS517364-5x001mg | 5x0.01mg | EUR 1500 |
PAK4 Peptide |
||
| 3077P | 0.05 mg | EUR 197.7 |
|
Description: (IN) PAK4 peptide |
||
PAK4 protein |
||
| 30R-2822 | 5 ug | EUR 425 |
|
Description: Purified recombinant Human PAK4 protein |
||
PAK4 Peptide |
||
| MBS153041-005mg | 0.05mg | EUR 175 |
PAK4 Peptide |
||
| MBS153041-5x005mg | 5x0.05mg | EUR 770 |
PAK1 siRNA (Rat) |
||
| MBS8230957-15nmol | 15nmol | EUR 405 |
PAK1 siRNA (Rat) |
||
| MBS8230957-30nmol | 30nmol | EUR 565 |
PAK1 siRNA (Rat) |
||
| MBS8230957-5x30nmol | 5x30nmol | EUR 2450 |
PAK7 siRNA (Rat) |
||
| MBS8225486-15nmol | 15nmol | EUR 405 |
PAK7 siRNA (Rat) |
||
| MBS8225486-30nmol | 30nmol | EUR 565 |
PAK7 siRNA (Rat) |
||
| MBS8225486-5x30nmol | 5x30nmol | EUR 2450 |
PAK3 siRNA (Rat) |
||
| MBS8219486-15nmol | 15nmol | EUR 405 |
PAK3 siRNA (Rat) |
||
| MBS8219486-30nmol | 30nmol | EUR 565 |
PAK3 siRNA (Rat) |
||
| MBS8219486-5x30nmol | 5x30nmol | EUR 2450 |
PAK2 siRNA (Rat) |
||
| MBS828816-15nmol | 15nmol | EUR 405 |
PAK2 siRNA (Rat) |
||
| MBS828816-30nmol | 30nmol | EUR 565 |
PAK2 siRNA (Rat) |
||
| MBS828816-5x30nmol | 5x30nmol | EUR 2450 |
PAK4 antibody |
||
| 20R-1576 | 100 ug | EUR 807.6 |
|
Description: Rabbit polyclonal PAK4 antibody |
||
PAK4 Antibody |
||
| 24183 | 100ul | EUR 479 |
PAK4 Antibody |
||
| 24183-100ul | 100ul | EUR 468 |
PAK4 Antibody |
||
| 3077-002mg | 0.02 mg | EUR 206.18 |
|
Description: PAK4 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6. These proteins are not activated by Cdc42/Rac binding. PAK4 was initially identified as a novel effector of Cdc42Hs. Co-expression of PAK4 and Cdc42Hs resulted in induction of filopodia and actin polymerization, showing that it is involved in cytoskeletal reorganization. Other experiments have shown PAK4 to be essential for embryonic viability and proper neuronal development. PAK4 has also been implicated in anchorage-independent growth of tumor cells and is required for activation of several cancer prosurvival pathways. |
||
PAK4 Antibody |
||
| 3077-01mg | 0.1 mg | EUR 523.7 |
|
Description: PAK4 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6. These proteins are not activated by Cdc42/Rac binding. PAK4 was initially identified as a novel effector of Cdc42Hs. Co-expression of PAK4 and Cdc42Hs resulted in induction of filopodia and actin polymerization, showing that it is involved in cytoskeletal reorganization. Other experiments have shown PAK4 to be essential for embryonic viability and proper neuronal development. PAK4 has also been implicated in anchorage-independent growth of tumor cells and is required for activation of several cancer prosurvival pathways. |
||
PAK4 Antibody |
||
| 35864 | 100ul | EUR 319 |
PAK4 Antibody |
||
| 35864-100ul | 100ul | EUR 302.4 |
PAK4 Antibody |
||
| 3444-100 | each | EUR 398.4 |
PAK4 Antibody |
||
| 3444-30T | each | EUR 175.2 |
PAK4 Antibody |
||
| 35447 | 100ul | EUR 479 |
PAK4 Antibody |
||
| 35447-100ul | 100ul | EUR 468 |
PAK4 antibody |
||
| 38462 | 100ul | EUR 439 |
PAK4 antibody |
||
| 38462-100ul | 100ul | EUR 302.4 |
PAK4 Antibody |
||
| E035864 | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
||
PAK4 Antibody |
||
| E19-7078 | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
||
PAK4 Antibody |
||
| 1-CSB-PA017408GA01HU |
|
|
|
Description: A polyclonal antibody against PAK4. Recognizes PAK4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
||
PAK4 Antibody |
||
| 1-CSB-PA006475 |
|
|
|
Description: A polyclonal antibody against PAK4. Recognizes PAK4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.IHC:1/200-1/1000.ELISA:1/40000 |
||
PAK4 Antibody |
||
| DF7078 | 200ul | EUR 420 |
PAK4 Antibody |
||
| DF7078-100ul | 100ul | EUR 280 |
PAK4 Antibody |
||
| DF7078-200ul | 200ul | EUR 350 |
PAK4 Antibody |
||
| E92782 | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
||
PAK4 Antibody |
||
| E300204 | 100ug | EUR 275 |
|
Description: Available in various conjugation types. |
||
PAK4 Antibody |
||
| E300204b | 100ug | EUR 275 |
|
Description: Available in various conjugation types. |
||
PAK4 antibody |
||
| 70R-11829 | 100 ug | EUR 364 |
|
Description: Rabbit polyclonal PAK4 antibody |
||
PAK4 antibody |
||
| 70R-19098 | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal PAK4 antibody |
||
PAK4 antibody |
||
| 70R-50787 | 100 ul | EUR 286 |
|
Description: Purified Polyclonal PAK4 antibody |
||
PAK4 Antibody |
||
| 1-CSB-PA038167 |
|
|
|
Description: A polyclonal antibody against PAK4. Recognizes PAK4 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
||
PAK4 Antibody |
||
| 1-CSB-PA05437A0Rb |
|
|
|
Description: A polyclonal antibody against PAK4. Recognizes PAK4 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:50-1:500 |
||
PAK4 Antibody |
||
| ABD7078 | 100ug | EUR 325 |
Pak4 Antibody |
||
| F43855-0.08ML | 0.08 ml | EUR 140.25 |
|
Description: Pak4 activates the JNK pathway. Plays a role in the reorganization of the actin cytoskeleton and in the formation of filopodia. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates ARHGEF2 (By similarity). |
||
Pak4 Antibody |
||
| F43855-0.4ML | 0.4 ml | EUR 322.15 |
|
Description: Pak4 activates the JNK pathway. Plays a role in the reorganization of the actin cytoskeleton and in the formation of filopodia. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates ARHGEF2 (By similarity). |
||
PAK4 Antibody |
||
| F50893-0.08ML | 0.08 ml | EUR 140.25 |
|
Description: PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3, PAK4, PAK5, and PAK6. PAK proteins serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases. PAK4 is a mediator of filopodia formation and may play a role in the reorganization of the actin cytoskeleton. |
||
PAK4 Antibody |
||
| F50893-0.4ML | 0.4 ml | EUR 322.15 |
|
Description: PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3, PAK4, PAK5, and PAK6. PAK proteins serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases. PAK4 is a mediator of filopodia formation and may play a role in the reorganization of the actin cytoskeleton. |
||
Pak4 Antibody |
||
| GWB-MR179H | 50ug | Ask for price |
PAK4 Antibody |
||
| K1E023M12G11C-100ug | 100 ug | EUR 360 |
|
Description: Monoclonal Antibody |
||
PAK4 Antibody |
||
| K1E023M12G11C-1mg | 1 mg | EUR 1800 |
|
Description: Monoclonal Antibody |
||
PAK4 Antibody |
||
| K1E023M12G11C-50ug | 50 ug | EUR 252 |
|
Description: Monoclonal Antibody |
||
PAK4 Antibody |
||
| MBS7124107-005mL | 0.05mL | EUR 190 |
PAK4 Antibody |
||
| MBS7124107-01mL | 0.1mL | EUR 270 |
PAK4 Antibody |
||
| MBS7124107-5x01mL | 5x0.1mL | EUR 1205 |
PAK4 Antibody |
||
| MBS7118865-005mg | 0.05mg | EUR 150 |
PAK4 Antibody |
||
| MBS7118865-01mg | 0.1mg | EUR 190 |
PAK4 Antibody |
||
| MBS7118865-5x01mg | 5x0.1mg | EUR 845 |